James K. Fong

Officer, CTI BioPharma.

Companies

CTI BioPharmaOfficer Mar 11, 2022 to Jun 26, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

CTI BioPharma0 shares²Jun 26, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 26, 2023U 3,565 shares at $9.10 of CTI BioPharma²
Jan 24, 2023Sold 100,000 shares at $6.00 of CTI BioPharma³
Jan 24, 2023Exercised options 100,000 shares at $0.95 of CTI BioPharma³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCTI BioPharma, Officer
2
SEC EDGARCTI BioPharma shares after the filing of Jun 26, 2023
3
SEC EDGARForm 4 filed Jan 26, 2023